| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |